PL3369816T3 - KOMPOZYCJA STABILNIE ZAWIERAJĄCA CZĄSTECZKĘ JEDNONICIOWEGO KWASU NUKLEINOWEGO, KTÓRA HAMUJE EKSPRESJĘ GENU TGF-β1 - Google Patents
KOMPOZYCJA STABILNIE ZAWIERAJĄCA CZĄSTECZKĘ JEDNONICIOWEGO KWASU NUKLEINOWEGO, KTÓRA HAMUJE EKSPRESJĘ GENU TGF-β1Info
- Publication number
- PL3369816T3 PL3369816T3 PL16859995.9T PL16859995T PL3369816T3 PL 3369816 T3 PL3369816 T3 PL 3369816T3 PL 16859995 T PL16859995 T PL 16859995T PL 3369816 T3 PL3369816 T3 PL 3369816T3
- Authority
- PL
- Poland
- Prior art keywords
- tgf
- nucleic acid
- acid molecule
- stranded nucleic
- containing single
- Prior art date
Links
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015215207 | 2015-10-30 | ||
| PCT/JP2016/082164 WO2017073767A1 (ja) | 2015-10-30 | 2016-10-28 | ＴＧＦ－β１遺伝子の発現を抑制する一本鎖核酸分子を安定に含有する組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3369816T3 true PL3369816T3 (pl) | 2024-07-22 |
Family
ID=58631737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16859995.9T PL3369816T3 (pl) | 2015-10-30 | 2016-10-28 | KOMPOZYCJA STABILNIE ZAWIERAJĄCA CZĄSTECZKĘ JEDNONICIOWEGO KWASU NUKLEINOWEGO, KTÓRA HAMUJE EKSPRESJĘ GENU TGF-β1 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10751426B2 (pl) |
| EP (1) | EP3369816B1 (pl) |
| JP (1) | JP6609637B2 (pl) |
| KR (1) | KR102099711B1 (pl) |
| CN (1) | CN108350457B (pl) |
| AU (1) | AU2016346703B2 (pl) |
| BR (1) | BR112018008613A2 (pl) |
| CA (1) | CA3002786C (pl) |
| ES (1) | ES2988534T3 (pl) |
| IL (1) | IL258861B (pl) |
| MX (1) | MX2018005146A (pl) |
| PL (1) | PL3369816T3 (pl) |
| RU (1) | RU2714257C2 (pl) |
| SG (1) | SG11201803410RA (pl) |
| WO (1) | WO2017073767A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI830718B (zh) * | 2018-02-09 | 2024-02-01 | 日商住友化學股份有限公司 | 核酸分子之製造方法 |
| BR112020017769A2 (pt) * | 2018-03-30 | 2021-01-05 | Toray Industries, Inc. | Método e kit para produzir uma molécula de rna de fita simples, e, molécula de oligorna de fita simples. |
| ES2981806T3 (es) * | 2018-10-02 | 2024-10-10 | Toray Industries | Método para producir moléculas de ARN monocatenario en horquilla |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU219445B (hu) * | 1992-09-17 | 2001-04-28 | Amgen Inc. | Interleukin-1 inhibitorokat tartalmazó, stabil gyógyszerkészítmények és eljárás előállításukra |
| JP4956727B2 (ja) * | 2005-08-30 | 2012-06-20 | 倉敷紡績株式会社 | Ｒｎａ分離精製方法 |
| TW201336514A (zh) | 2006-04-13 | 2013-09-16 | Alcon Res Ltd | ＲＮＡ干擾（ＲＮＡｉ）所媒介之與脾酪胺酸激酶相關之發炎症狀的抑制作用（二） |
| JP2010505396A (ja) * | 2006-10-06 | 2010-02-25 | ディーエヌエー ジェノテック インク | リボ核酸を抽出するための安定化組成物および方法 |
| CA2709875C (en) | 2008-01-02 | 2019-07-16 | Tekmira Pharmaceuticals Corporation | Improved compositions and methods for the delivery of nucleic acids |
| JP5608998B2 (ja) * | 2009-03-31 | 2014-10-22 | 東洋紡株式会社 | 保存安定性に優れた核酸増幅検出試薬キット |
| CN102821782B (zh) | 2010-02-12 | 2015-07-15 | 印塔斯生物制药有限公司 | 促卵泡激素的液体配制品 |
| KR20180044433A (ko) * | 2010-03-24 | 2018-05-02 | 알엑스아이 파마슈티칼스 코포레이션 | 진피 및 섬유증성 적응증에서의 ｒｎａ 간섭 |
| US8785121B2 (en) | 2010-07-08 | 2014-07-22 | Bonac Corporation | Single-stranded nucleic acid molecule for controlling gene expression |
| ES2550487T3 (es) | 2010-07-08 | 2015-11-10 | Bonac Corporation | Molécula de ácido nucleico monocatenario para controlar la expresión génica |
| US8691782B2 (en) * | 2010-08-03 | 2014-04-08 | Bonac Corporation | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
| ES2528285T3 (es) | 2010-08-03 | 2015-02-06 | Bonac Corporation | Molécula de ácido nucleico monocatenario que tiene esqueleto alicíclico que contiene nitrógeno |
| KR20190006576A (ko) | 2010-08-16 | 2019-01-18 | 오스트레일리안 뉴클리어 사이언스 앤드 테크놀로지 오가니제이션 | 생체분자의 전달을 위한 세라믹 입자를 포함하는 미립자 물질 및 미립자 물질을 포함하는 약학적 조성물 |
| AR083445A1 (es) * | 2010-10-14 | 2013-02-27 | Univ Mie | siARN CONTRA LA FIBROSIS |
| KR20130139254A (ko) | 2010-11-09 | 2013-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부 침투 및 세포 진입（ｓｐａｃｅ） 펩타이드 및 그의 사용방법 |
| JP5854595B2 (ja) | 2010-12-07 | 2016-02-09 | 株式会社Ｓｈｏｅｉ | ヘルメット用ラチェットバックル |
| WO2013077446A1 (ja) | 2011-11-26 | 2013-05-30 | 株式会社ボナック | 遺伝子発現制御のための一本鎖核酸分子 |
| SI2791160T1 (sl) * | 2011-12-16 | 2022-07-29 | Modernatx, Inc. | Sestave modificirane MRNA |
| CN110055247A (zh) | 2012-01-07 | 2019-07-26 | 株式会社博纳克 | 具有氨基酸骨架的单链核酸分子 |
| WO2013133393A1 (ja) | 2012-03-07 | 2013-09-12 | 学校法人東京医科大学 | Ｖｅｇｆ遺伝子の発現抑制用一本鎖核酸分子 |
| SI2828332T1 (sl) * | 2012-03-21 | 2017-09-29 | Engene, Inc. | Dvojno derivatizirani hitozan nanodelci in postopki za izdelavo in uporabo istih za in vivo transfer gena |
| WO2014059430A1 (en) * | 2012-10-14 | 2014-04-17 | Board Of Regents, The University Of Texas System | Delivery of small interfering rna and micro rna through membrane-disruptive, responsive nanoscalle hydrogels |
| CN102895190A (zh) * | 2012-10-16 | 2013-01-30 | 百奥迈科生物技术有限公司 | 脂质体制剂、制备方法及其应用 |
| CN105051064A (zh) | 2013-01-24 | 2015-11-11 | 葛兰素史克知识产权开发有限公司 | 抗TNF-α抗原结合蛋白 |
| CA2888286C (en) | 2013-03-06 | 2020-03-24 | Biomics Biotechnologies Co., Ltd. | Liposome formulation, its preparation and application |
| WO2015093495A1 (ja) | 2013-12-16 | 2015-06-25 | 株式会社ボナック | ＴＧＦ－β１遺伝子発現制御のための一本鎖核酸分子 |
| CN106068324B (zh) * | 2013-12-27 | 2020-12-29 | 株式会社博纳克 | 控制基因表达的人工匹配型miRNA及其用途 |
| SG11201705312PA (en) * | 2014-12-29 | 2017-07-28 | Bonac Corp | Composition containing nucleic acid molecule stably |
-
2016
- 2016-10-28 PL PL16859995.9T patent/PL3369816T3/pl unknown
- 2016-10-28 ES ES16859995T patent/ES2988534T3/es active Active
- 2016-10-28 MX MX2018005146A patent/MX2018005146A/es unknown
- 2016-10-28 US US15/771,305 patent/US10751426B2/en not_active Expired - Fee Related
- 2016-10-28 EP EP16859995.9A patent/EP3369816B1/en active Active
- 2016-10-28 BR BR112018008613-4A patent/BR112018008613A2/pt not_active Application Discontinuation
- 2016-10-28 JP JP2017547914A patent/JP6609637B2/ja active Active
- 2016-10-28 AU AU2016346703A patent/AU2016346703B2/en active Active
- 2016-10-28 RU RU2018119672A patent/RU2714257C2/ru active
- 2016-10-28 CA CA3002786A patent/CA3002786C/en active Active
- 2016-10-28 CN CN201680064120.5A patent/CN108350457B/zh not_active Expired - Fee Related
- 2016-10-28 WO PCT/JP2016/082164 patent/WO2017073767A1/ja not_active Ceased
- 2016-10-28 KR KR1020187015234A patent/KR102099711B1/ko active Active
- 2016-10-28 SG SG11201803410RA patent/SG11201803410RA/en unknown
-
2018
- 2018-04-23 IL IL258861A patent/IL258861B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3002786A1 (en) | 2017-05-04 |
| US10751426B2 (en) | 2020-08-25 |
| RU2018119672A (ru) | 2019-12-02 |
| KR102099711B1 (ko) | 2020-04-14 |
| WO2017073767A1 (ja) | 2017-05-04 |
| AU2016346703B2 (en) | 2020-07-02 |
| CA3002786C (en) | 2021-09-07 |
| IL258861B (en) | 2021-12-01 |
| ES2988534T3 (es) | 2024-11-20 |
| HK1258326A1 (en) | 2019-11-08 |
| EP3369816A1 (en) | 2018-09-05 |
| AU2016346703A1 (en) | 2018-06-21 |
| CN108350457B (zh) | 2021-10-01 |
| KR20180066250A (ko) | 2018-06-18 |
| MX2018005146A (es) | 2018-08-23 |
| EP3369816A4 (en) | 2019-06-26 |
| CN108350457A (zh) | 2018-07-31 |
| RU2714257C2 (ru) | 2020-02-13 |
| SG11201803410RA (en) | 2018-05-30 |
| EP3369816B1 (en) | 2024-03-13 |
| RU2018119672A3 (pl) | 2019-12-02 |
| IL258861A (en) | 2018-06-28 |
| JP6609637B2 (ja) | 2019-11-20 |
| US20180339064A1 (en) | 2018-11-29 |
| JPWO2017073767A1 (ja) | 2018-10-04 |
| BR112018008613A2 (pt) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL294192A (en) | Sequencing a single molecule of DNA. plasma | |
| LT3129487T (lt) | Patobulinti nukleorūgščių konstruktai, skirti eukariotinio geno raiškai | |
| IL252556A0 (en) | Nucleic acid constructs for genome editing | |
| IL256905A (en) | Methods for Amplifying Nucleic Acid Sequences | |
| SG11201911430PA (en) | Novel nucleic acid molecules | |
| GB201903914D0 (en) | De novo synthesized nucleic acid libraries | |
| IL249619A0 (en) | Analysis of nucleic acid sequences | |
| LT3337902T (lt) | 3` utr sekos, skirtos rnr stabilizavimui | |
| ZA201702211B (en) | Nucleic acid purification cartridge | |
| PL3094731T3 (pl) | Cząsteczki kwasu nukleinowego zmodyfikowane sacharydem | |
| IL252905B (en) | A preparation that includes a stable nucleic acid molecule | |
| EP3323893A4 (en) | BETA2GPI GENE EXPRESSION-INHIBITING NUCLEIC ACID COMPLEX | |
| GB201711603D0 (en) | Method for constructing nucleic acid molecule | |
| IL255998A (en) | Preparations and methods for suppressing the expression of the hif2alpha strain | |
| SG10201912967YA (en) | Determination of nucleic acid methylation | |
| EP3165612A4 (en) | Method for counting number of nucleic acid molecules | |
| IL254304A0 (en) | Nucleoside agents to reduce negative effects of genes involving elongated nucleotide repeats | |
| EP3036343A4 (en) | Helicase dependent amplification of dna molecules using nucleotide analogs | |
| DK3325621T3 (da) | Kloning af en-strenget nucleinsyre | |
| IL258861B (en) | A stable preparation that includes a single-helical nucleic acid compound that suppresses the expression of the tumor growth factor-beta 1 gene | |
| EP3631006A4 (en) | DNA STABILIZATION OF RNA | |
| IL255081A0 (en) | Identification of nucleic acid molecules | |
| EP3095867A4 (en) | Nucleic acid capable of inhibiting expression of beta2gpi | |
| EP3235906A4 (en) | Single-stranded nucleic acid molecule for inhibiting tgf- beta 1 expression | |
| EP3696270A4 (en) | REGULATION OF THE EXPRESSION OF NUCLEIC ACID MOLECULES |